This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Yuji Akiyama: Inventor in Pharmaceutical Research.
Introduction
Yuji Akiyama is an inventor associated with Saitama, Japan, and Nippon Kayaku Kabushiki Kaisha. His patent work concerns a pharmaceutical compound intended to modulate immune responses.
Latest Patents
Akiyama is credited with 1 patent: “[1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof.” The patent describes a novel [1,2,4]triazolo[1,5-a]pyrimidine derivative, its prodrug, or a pharmaceutically acceptable salt. The compound is described as inhibiting antigen presentation and as potentially useful in preventing or treating transplant rejection, graft-versus-host reactions, autoimmune and allergic diseases, and inflammatory conditions. The patent also identifies potential applications as an anticancer drug and as an inducer of immunological tolerance for transplanted organs or bone marrow.
Career Highlights
Akiyama’s listed invention reflects pharmaceutical research focused on immune regulation and potential therapeutic applications. The supplied information associates his work with Nippon Kayaku Kabushiki Kaisha.
Collaborations
Yoshitaka Satoh and Kan Saiga are identified as Akiyama’s coworkers. The available information does not specify their roles in the patent or the extent of their collaboration.
Conclusion
Yuji Akiyama’s recorded patent centers on a compound with proposed applications in immunology, transplantation, and cancer treatment, reflecting the pharmaceutical research associated with his work at Nippon Kayaku Kabushiki Kaisha.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile